Patents by Inventor Dennis E. Saadeh

Dennis E. Saadeh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • EXTENDED-RELEASE PHARMACEUTICAL COMPOSITIONS FOR TREATING EYE CONDITIONS
    Publication number: 20250186415
    Abstract: The present disclosure encompasses methods and compositions for extended-release formulations for treating ophthalmic conditions. These formulations comprise a pharmaceutical agent, a cationic polymer, a non-ionic polymer, and a pharmaceutical carrier and are essentially preservative free. The formulations provided herein are particularly useful for sustained and controlled release of drugs and have low side effects.
    Type: Application
    Filed: March 7, 2022
    Publication date: June 12, 2025
    Inventors: Dennis E. Saadeh, Mark L. Baum, Richard L. Lindstrom
  • EXTENDED-RELEASE PHARMACEUTICAL COMPOSITIONS FOR TREATING EYE CONDITIONS
    Publication number: 20240423970
    Abstract: The present disclosure encompasses methods and compositions for extended-release formulations for treating ophthalmic conditions. These formulations comprise a pharmaceutical agent, a cationic polymer, a non-ionic polymer, and a pharmaceutical carrier and are essentially preservative free. The formulations provided herein are particularly useful for sustained and controlled release of drugs and have low side effects.
    Type: Application
    Filed: September 6, 2024
    Publication date: December 26, 2024
    Inventors: Dennis E. Saadeh, Mark L. Baum, Richard L. Lindstrom
  • EXTENDED-RELEASE PHARMACEUTICAL COMPOSITIONS FOR TREATING EYE CONDITIONS
    Publication number: 20230277521
    Abstract: The present disclosure encompasses methods and compositions for extended-release formulations for treating ophthalmic conditions. These formulations comprise a pharmaceutical agent, a cationic polymer, a non-ionic polymer, and a pharmaceutical carrier and are essentially preservative free. The formulations provided herein are particularly useful for sustained and controlled release of drugs and have low side effects.
    Type: Application
    Filed: March 7, 2022
    Publication date: September 7, 2023
    Inventors: Dennis E. Saadeh, Mark L. Baum, Richard L. Lindstrom